| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
89,262 |
79,427 |
$8.12M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
40,159 |
34,109 |
$2.82M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
9,990 |
8,526 |
$1.53M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,406 |
11,605 |
$1.18M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,661 |
6,969 |
$904K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,155 |
7,300 |
$562K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,379 |
5,037 |
$445K |
| 80047 |
|
18,360 |
14,843 |
$425K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,871 |
1,685 |
$415K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,671 |
3,407 |
$388K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
741 |
661 |
$166K |
| 80053 |
Comprehensive metabolic panel |
19,310 |
15,933 |
$163K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,252 |
1,923 |
$147K |
| 87070 |
|
6,108 |
5,771 |
$114K |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,325 |
4,462 |
$111K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,196 |
8,256 |
$77K |
| 81003 |
|
12,355 |
10,891 |
$76K |
| A9270 |
Non-covered item or service |
12,049 |
3,532 |
$71K |
| 71045 |
Radiologic examination, chest; single view |
27,054 |
21,989 |
$62K |
| 87430 |
|
15,029 |
14,267 |
$53K |
| 12001 |
|
556 |
522 |
$47K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,433 |
18,869 |
$46K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,641 |
1,318 |
$46K |
| 72131 |
|
587 |
489 |
$42K |
| 73610 |
|
1,495 |
1,373 |
$42K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,571 |
9,354 |
$41K |
| 73630 |
|
2,039 |
1,854 |
$38K |
| 85027 |
|
45,286 |
35,303 |
$37K |
| 71250 |
|
1,046 |
826 |
$37K |
| 71046 |
Radiologic examination, chest; 2 views |
3,361 |
2,966 |
$36K |
| 73130 |
|
1,468 |
1,347 |
$36K |
| 81001 |
|
9,372 |
8,269 |
$36K |
| 73562 |
|
1,757 |
1,549 |
$36K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,115 |
2,585 |
$35K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
898 |
803 |
$34K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,325 |
4,386 |
$33K |
| 87449 |
|
2,205 |
2,022 |
$31K |
| 73030 |
|
1,595 |
1,362 |
$29K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
232 |
107 |
$29K |
| 84702 |
|
1,496 |
1,221 |
$27K |
| G0378 |
Hospital observation service, per hour |
3,494 |
1,891 |
$25K |
| 73110 |
|
1,062 |
966 |
$24K |
| 12011 |
|
272 |
255 |
$24K |
| 84484 |
|
21,613 |
16,015 |
$23K |
| 80076 |
|
15,639 |
12,816 |
$23K |
| 84703 |
|
3,557 |
3,274 |
$22K |
| 74018 |
|
1,277 |
1,155 |
$20K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,532 |
15,895 |
$20K |
| 80306 |
|
2,798 |
2,442 |
$20K |
| 76641 |
|
214 |
200 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
1,668 |
1,359 |
$19K |
| 82803 |
|
12,538 |
9,820 |
$18K |
| 87077 |
|
2,749 |
2,239 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,487 |
2,748 |
$17K |
| 93976 |
|
1,688 |
1,513 |
$17K |
| 12002 |
|
261 |
244 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
642 |
590 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,168 |
2,025 |
$15K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
294 |
266 |
$15K |
| 72100 |
|
948 |
837 |
$15K |
| 87040 |
|
14,966 |
11,247 |
$15K |
| 76830 |
Ultrasound, transvaginal |
1,040 |
948 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,741 |
6,494 |
$13K |
| 87280 |
|
886 |
868 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,522 |
10,843 |
$11K |
| 83735 |
|
12,189 |
9,549 |
$10K |
| 70486 |
|
165 |
150 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,181 |
1,090 |
$10K |
| 10060 |
|
157 |
142 |
$10K |
| 73140 |
|
329 |
306 |
$10K |
| 85610 |
|
10,724 |
8,519 |
$9K |
| 73502 |
|
565 |
464 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,185 |
7,100 |
$9K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
347 |
95 |
$9K |
| 83880 |
|
7,002 |
5,492 |
$9K |
| 82550 |
|
7,614 |
5,737 |
$8K |
| 73090 |
|
306 |
273 |
$8K |
| 85730 |
|
6,522 |
5,271 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,035 |
3,291 |
$7K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
764 |
564 |
$7K |
| 83690 |
|
15,842 |
12,897 |
$7K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,931 |
1,733 |
$7K |
| 93971 |
|
599 |
502 |
$7K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
274 |
256 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,903 |
3,155 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
268 |
216 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,990 |
9,239 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,635 |
13,883 |
$6K |
| 83605 |
|
16,042 |
12,575 |
$5K |
| 71101 |
|
145 |
130 |
$5K |
| 73080 |
|
386 |
344 |
$5K |
| 73590 |
|
351 |
316 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
535 |
394 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,847 |
5,533 |
$4K |
| 73700 |
|
47 |
36 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
611 |
440 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
45 |
40 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,684 |
2,179 |
$4K |
| 80061 |
Lipid panel |
1,713 |
1,383 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
243 |
177 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
734 |
401 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,458 |
6,912 |
$3K |
| 82330 |
|
597 |
502 |
$3K |
| 72050 |
|
135 |
125 |
$3K |
| 70496 |
|
15 |
14 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
272 |
189 |
$3K |
| 82565 |
|
275 |
217 |
$3K |
| 84100 |
|
2,116 |
1,564 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,389 |
1,697 |
$3K |
| 76770 |
|
64 |
61 |
$3K |
| 87186 |
|
2,491 |
2,002 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
864 |
511 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
55 |
51 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,896 |
2,109 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
794 |
589 |
$2K |
| 81025 |
|
2,872 |
2,661 |
$2K |
| 73560 |
|
88 |
75 |
$2K |
| 36430 |
|
32 |
26 |
$2K |
| 72040 |
|
75 |
65 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,312 |
1,073 |
$1K |
| 82553 |
|
341 |
204 |
$1K |
| 96376 |
|
1,568 |
1,057 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
81 |
70 |
$1K |
| 73600 |
|
17 |
14 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,188 |
1,096 |
$1K |
| 80320 |
|
310 |
276 |
$897.14 |
| 86140 |
|
2,377 |
1,941 |
$830.53 |
| 82248 |
|
1,496 |
1,131 |
$792.65 |
| 85378 |
|
821 |
729 |
$755.25 |
| 70498 |
|
18 |
16 |
$570.61 |
| 87205 |
|
1,357 |
1,032 |
$566.59 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
126 |
111 |
$563.65 |
| 86885 |
|
555 |
463 |
$556.03 |
| 73552 |
|
14 |
12 |
$554.97 |
| 85651 |
|
1,390 |
1,161 |
$551.51 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
770 |
653 |
$528.35 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
562 |
453 |
$528.35 |
| 82077 |
|
917 |
755 |
$457.49 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
14 |
$429.55 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
629 |
522 |
$396.02 |
| 90715 |
|
750 |
668 |
$375.26 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
168 |
148 |
$350.19 |
| 87807 |
|
611 |
596 |
$315.02 |
| 72070 |
|
72 |
68 |
$312.94 |
| 74019 |
|
17 |
16 |
$297.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
885 |
735 |
$275.36 |
| 29125 |
|
33 |
29 |
$263.39 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
173 |
141 |
$241.23 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
781 |
557 |
$212.04 |
| 82607 |
|
85 |
72 |
$179.89 |
| 87400 |
|
3,147 |
2,932 |
$148.35 |
| 84439 |
|
200 |
154 |
$144.93 |
| 70360 |
|
13 |
12 |
$141.58 |
| 73060 |
|
16 |
12 |
$132.98 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
271 |
220 |
$125.45 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,039 |
921 |
$119.38 |
| 85379 |
|
101 |
87 |
$117.81 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
62 |
60 |
$102.48 |
| 77066 |
Tomosynthesis, mammo |
42 |
41 |
$97.25 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
35 |
27 |
$93.20 |
| 86920 |
|
21 |
15 |
$88.41 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
274 |
149 |
$60.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
413 |
296 |
$58.74 |
| J2060 |
Injection, lorazepam, 2 mg |
826 |
650 |
$36.39 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
3,057 |
2,923 |
$21.34 |
| 84480 |
|
208 |
157 |
$16.04 |
| 86901 |
|
699 |
567 |
$6.92 |
| 36600 |
|
16 |
12 |
$4.53 |
| C9113 |
Injection, pantoprazole sodium, per vial |
272 |
177 |
$3.74 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
311 |
288 |
$0.17 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
495 |
438 |
$0.00 |
| 80329 |
|
332 |
311 |
$0.00 |
| 83615 |
|
15 |
13 |
$0.00 |
| 76801 |
|
53 |
48 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
216 |
200 |
$0.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
43 |
42 |
$0.00 |
| J3490 |
Unclassified drugs |
28 |
27 |
$0.00 |
| 82150 |
|
39 |
25 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
121 |
81 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
101 |
66 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
16 |
12 |
$0.00 |
| 87088 |
|
14 |
13 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
907 |
795 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
186 |
139 |
$0.00 |
| 82140 |
|
232 |
172 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
57 |
42 |
$0.00 |
| 86900 |
|
588 |
463 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
64 |
59 |
$0.00 |
| 87420 |
|
29 |
28 |
$0.00 |
| 87210 |
|
45 |
44 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
56 |
41 |
$0.00 |
| 82009 |
|
39 |
25 |
$0.00 |
| 82310 |
|
40 |
26 |
$0.00 |